SEC Filing Summary: PowerUp Acquisition Corp. (8-K)
Business Context and Reporting Period
This Current Report on Form 8-K was filed by PowerUp Acquisition Corp. (not Aspire Biopharma Holdings, Inc.) on May 16, 2024. The registrant is a Cayman Islands-based special purpose acquisition company (SPAC) listed on The Nasdaq Stock Market LLC under the symbols PWUPU, PWUP, and PWUPW. The filing addresses an "Other Event" regarding the postponement of a scheduled extraordinary general meeting of shareholders.
Key Financial Metrics
The filing text does not provide specific financial data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. As a SPAC in the pre-business combination phase, this report focuses on corporate governance and shareholder meeting logistics rather than operational financial performance.
Material Changes and Corporate Actions
- Meeting Postponement: The extraordinary general meeting originally scheduled for May 17, 2024, has been postponed to 9:00 a.m. Eastern Time on Tuesday, May 21, 2024.
- Extension Proposal: Shareholders will vote to extend the deadline to consummate an initial business combination from May 23, 2024, to February 17, 2025.
- Redemption Deadline: The deadline for shareholders to submit publicly held shares for redemption has been extended to 5:00 p.m. Eastern Time on Friday, May 17, 2024.
- Withdrawal of Requests: Shareholders who previously submitted redemption requests may withdraw them by contacting the transfer agent prior to the new redemption deadline.
Guidance, Outlook, and Risks
The filing contains standard forward-looking statements regarding the meeting and the potential extension of the business combination deadline. Management notes that actual results could differ materially due to factors outlined in the Company's Risk Factors section of its Form 10-K and other SEC filings. The filing explicitly states it does not constitute an offer to sell or a solicitation of an offer to buy securities.
Investor Verification Checklist
- Verify the new meeting date (May 21, 2024) and time (9:00 a.m. ET) for voting on the extension proposal.
- Confirm the final deadline for share redemptions (May 17, 2024, at 5:00 p.m. ET).
- Review the Definitive Proxy Statement on Schedule 14A (filed April 26, 2024) for details on the extension terms and participant interests.
- Check the status of any previously submitted redemption requests if withdrawal is desired.
- Monitor the Company's filings for updates on the progress toward an initial business combination by the new February 17, 2025 deadline.